Arsenical keratoses and carcinomas;Le cas clinique du mois: Kératoses et carcinomes arsénicaux

Revue Medicale de Liege

Volumn 60, Issue 4, 2005, Pages 217-221

  Fumal, I ^a   Pierard Franchimont C ^a,b   Pierard G E ^b  

^a Centre Hospitalier Hutois   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Arsenic; Basal cell carcinoma; Cancer; Chemical cancerogenesis

Indexed keywords

ARSENIC;

AGED; ARSENIC POISONING; ARTICLE; BASAL CELL CARCINOMA; BRAIN METASTASIS; CANCER INVASION; CANCER PATIENT; CANCER RISK; CASE REPORT; CHEMICAL CARCINOGENESIS; HUMAN; KERATOSIS; KERATOSIS PALMOPLANTARIS; MALE; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA;

AGED; ARSENIC; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; HUMANS; KERATOSIS; MALE; PSORIASIS; SKIN NEOPLASMS;

EID: 19044385793     PISSN: 00353663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Neubauer O.- Arsenical cancer: a review. Br J Cancer, 1947, 1, 192-251.
2. Robertson WO.- Arsenic and other heavy metals. In: Haddad LM, Winchester JF (eds). Clnical management of poisoning and drug overdose. W. Saunders, Philadelphia, PA, 1983, chap 59, p 656.
3. Schwartz RA.- Arsenicism and the skin. Int J Dermatol, 1997, 36, 241-250.
4. Nevens F, Fevery J, Van Steenbergen W.- Arsenic and non-cirrhotic portal hypertension. A report of eight cases. J. Hepatol, 1990, 11, 80-85.
5. Bettley FR, O'Shea JA.- The absorption of arsenic and its relation to carcinoma. Br J. Dermatol, 1975, 92, 563-568.
6. Centeno JA, Mullick FG, Martinez L et al.- Pathology related to chronic arsenic exposure. Environ Health Perspect, 2002, 110 Suppl, 5, 883-886.
7. Col M, Col C, Soran A et al.- Arsenic-related Bowen's disease, palmar keratosis and skin cancer. Environ Healt Perspect, 1999, 107, 687-689.
8. Bourgeois AM, Avenel Audran M, Le Bouil A, et al.- Arsėnicisme chronique. Ann Dermatol Venereol, 2001, 128, 527-530.
9. Lien HC, Tsai TF, Lee YY, et al.- Merckel cell carcinoma and chronic arsenicism. J Am Acad Dermatol, 1999, 41, 641-643.
10. Le Cam MT, Pairon JC.- L'arsénicisme chronique (éditorial). Ann Dermatol Venereal, 2001, 128, 493-495.
11. Das D, Chatterjee A, Mandal BIC et al.- Arsenic in ground water in six districts of west Bengal, India: the biggest arsenic calamity in the world. Part 2 - Arsenic concentration in drinking water, hair, nails, urine, skin-scale and liver tissue (biopsy) of the affected people. Analyst, 1995, 120, 917-924.
12. Wong SS, Tan KC, Goh CL.- Cutaneous manifestations of chronic arsenicism: review of seventeen cases. J Am Acad Dermatol, 1998, 38, 179-185.
13. Sass V, Grosshans E, Simonart JM.- Chronic arsenicism: criminal poisoning or drug-intoxication? Report of two cases. Dermatology, 1993, 186, 303-305.
14. Saha KC.- Diagnosis of arsenicosis. J. Environ Sci Health. Part a Tox Hazard Subst Environ Eng, 2003, 38, 255-272.
15. Yerebakan O, Ermis O, Yilmas E, et al.- Treatment of arsenical keratosis and Bowen's disease with acitretin. Int J Dermatol, 2002, 41, 84-87
16. Poljacki M, Stojanovic S, Svilar V- The importance of local administration of 5% 5-fluorouraril in the therapy of senile keratoses and basocellular carcinoma. Med Pregl, 1989, 42, 149-151.
17. Cowen E, Mercurio M, Gaspari A, et al.- An open cases series of patients with basal cell carcinoma treated with topical 5% imiquimod cream. J Am Acad Dermatol, 2002, 47, 5240-5248.
18. Hermanns-Lê J, Nikkels A, Uhoda I, et al.- L'imiquimod (Aldara°): un immunomodulateur pour la peau. Rev Med Liège, 2002, 57, 116-118.
19. Uhoda I, Quatresooz P, Piérard GE.- Nudging epidermal field cancerogenesis by imiquimod. Dermatology, 2003, 206, 357-360.
20. Hermanns-Lê T, Paquet P, Nikkels AJ, et al.- Prolonged imiquimod treatment and graft-versus-host reaction : histological mimicry in the pattern of monocyte-macrophage-dendrocyte lineage skin infiltration. Dermatology 2003, 206, 361-365.
21. Quatresooz P, Piérard GE.- Imiquimod-responsive basal cell carcinomas and factor XIIIa-enriched dendrocytes. Clin Exp Dermatol, 2003, 28, S27-S29.
22. Nikkels AF, Nikkels-Tassoudji N, Piérard GE.- Imiquimod-induced regression of superficial basal cell carcinoma: implication of factor XIIIa+ dermal dendrocytes. Clin Exp Dermatol, sous presse.